甲胺诱导的受体周转改变了HER表达瘤中的抗体积累
Sandeep Surendra Panikar1, Nai Keltee1, Na-Keysha Berry1
1Department of Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.
概括
甲福明降低了癌细胞上的人类表皮生长因子受体 (HER),降低了用于成像和治疗的抗体结合. 这种效应是剂量依赖和可逆的,影响癌症治疗策略.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 分子成像学分子成像学
背景情况:
- 甲胺除了降低葡萄糖,还表现出抗癌作用.
- 甲胺改变了癌细胞中的膜受体定位,特别是降低了人体表皮生长因子受体 (HER) 密度.
- 减少细胞表面HER表达可以阻碍基于抗体的癌症成像和治疗.
研究的目的:
- 在小鼠模型中使用向HER的正子发射断层扫描 (PET) 调查甲胺对HER受体密度和抗体与瘤结合的影响.
- 评估甲胺对 HER 受体局部化和瘤中抗体积累的剂量和时间依赖性影响.
主要方法:
- 采用小动物PET成像来评估HER表达异体移植中的放射性标记抗HER抗体结合.
- 小鼠接受了急性或每日剂量的甲福明.
- 进行蛋白质分析,包括细胞分离和免疫光,以量化HER受体水平 (总,膜,内化) 和酸化.
主要成果:
- 与对照组相比,急性甲福明的使用暂时降低了瘤中的抗体积累.
- 每天的甲福明治疗导致瘤抗体吸收持续减少.
- 甲胺诱导的细胞表面HER受体枯竭在停止治疗后是可逆的.
- 通过各种蛋白质分析试验证实了时间和剂量依赖的影响.
结论:
- 甲胺显著降低细胞表面HER受体表达时间和剂量依赖的方式.
- 这种减少HER密度会损害抗体与瘤的结合,影响诊断成像和治疗应用.
- 这些发现对于优化基于抗体的癌症疗法和分子成像策略在接受甲福林治疗的患者中具有关键意义.
更多相关视频
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
2.7K
11:02Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018
7.8K
相关概念视频
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Insulin: The Receptor and Signaling Pathways
1.3K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.3K
